16 November 2021

Teodora Grigore is telling about her experience winning the 2020 RIMLS travel grant in her own words: 

Last year (2020) I was fortunate to be awarded a within - EU RIMLS travel grant to support my research collaboration with the Karolinska Institute in Sweden. It was very exciting yet intriguing to hear the news – knowing that in spite of the great opportunity to visit one of the best research institutes of Europe, I might not be able to leave the Netherlands (or, even worse, not be able to come back) due to the COVID-19 restrictions. Luckily, I was able to travel in August, as restrictions were lifted at the time, and the vaccination rates improved. My research visit was very productive, as I had the opportunity of working with samples from a cohort of over 400 patients diagnosed with chronic kidney disease. Currently we are preparing an experimental paper with the results obtained from this research visit.

On a personal note, I was very happy to meet people from diverse backgrounds and to work in a different environment and learn novel techniques.

Thanks to the RIMLS travel grant, our department is already working on more projects with the Renal Medicine Division of the Karolinska Institute, thus nicely combining different perspectives and expertise in obtaining innovative and impactful results.

by Teodora Grigore

  • Want to know more about these subjects? Click on the buttons below for more news.

    RIMLS

Related news items


Human pluripotent stem cell-derived kidney organoids for personalized congenital and idiopathic nephrotic syndrome modeling

11 May 2022

Bart Smeets, Jitske Jansen and collegues, theme Renal disorders published this article in the Human Development.

read more

Mani Diba joins the Department of Dentistry as Hypatia Tenure Track Fellow

10 May 2022

Mani Diba recently re-joined Radboudumc as an Hypatia Tenure Track Fellow at the research group Regenerative Biomaterials of the Department of Dentistry.

read more

Combining targeted radionuclide therapy and immune checkpoint inhibition for cancer treatment

4 May 2022

Simone Kleinendorst, Sandra Heskamp and colleagues, theme Rare cancers, published in Clinical Cancer Research about their research on combined radionuclide therapy and immunotherapy for cancer treatment.

read more